ALKERMES | ALKS - Resultado Líquido

Preço das Ações
27.84
Mudança Diária
-0.16 -0.57%
Mensal
-15.38%
Anual
-19.00%
Q1 Previsão
26.93




Resultado Líquido Alterar Data
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -56.57M 5.87M 2025-03
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.12B 36M 2025-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Otsuka Holdings JPY 65.49B 58.64B 2025-12
Ovoca Bio EUR -5.65M 3.28M 2022-06
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12